In ER+/HER2− breast cancer cell models, a significant correlation was observed between the cell line sensitivity (AUC) of a KAT6‐specific inhibitor and the BRPF1 dependency score of KAT6A as compared with KAT6B [180]. This evidence concerns the gene KAT6A and breast carcinoma.